Home » Newsletters » BioWorld Science

BioWorld Science

May 23, 2002

View Archived Issues

rSP-C surfactant treatment tends to reduce mortality in patients with ARDS

Merck and Tularik present novel HIV integrase inhibitors

Novel MMP inhibitors identified by Pfizer research group

Gastric antisecretory agents patented by Byk Gulden

Novel retinoids and their use in pulmonary emphysema, cancer and skin disorders

NMDA channel blockers identified by U.S. university researchers

Prednisone prolongs survival in multiple myeloma patients

Novel protein kinase inhibitors discovered at Pfizer

Genta initiates gallium nitrate program for NHL

Antibacterial and antiinflammatory agents claimed by SUNY

Antisense compound identified with potential in cardiovascular disease

HGS and CAT to develop TRAIL-R2 MAb

ISS-1018 enters phase I in asthma

Amantadine as an effective and safe alternative to interferon in HCV infection

Selective CCKB/gastrin receptor antagonist evaluated in rat model of GERD

Rabeprazole effective for heartburn and symptoms of NERD

Novel antidiabetic lowers only elevated blood glucose levels and stimulates insulin release

Antigen-induced bronchospasm ameliorated by treatment with SOD mimetic

New data on treprostinil discussed at ATS 2002

Blockade of IL-5 with MAb selectively reduces eosinophils in bone marrow and peripheral blood

Low-dose formulation of Retin-A Micro approved by FDA

NicOx and Axcan sign codevelopment and license agreement for NCX-1000 in chronic liver diseases

Panacea receives SBIR grant for anti-HAAH cancer drugs

FDA advisory committee supports efficacy of Prevnar in otitis media

Pharmagene and Argenta Discovery collaborate on migraine and IBS programs

Restoragen restructures and refocuses

Phase I trial begins for first candidate to emerge from Vernalis/Roche obesity collaboration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...